Literature DB >> 23812342

Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness.

Andrew Quartin, Roland Schein, Cynthia Cely.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23812342     DOI： 10.1007/s00134-013-3005-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis.

Authors:  Eric A J Hoste; Severine Doom; Jan De Waele; Louke J Delrue; Luc Defreyne; Dominique D Benoit; Johan Decruyenaere
Journal:  Intensive Care Med       Date:  2011-11-03       Impact factor: 17.440

2.  Acute kidney injury in the critically ill: is iodinated contrast medium really harmful?

Authors:  Stephan Ehrmann; Julie Badin; Laurent Savath; Olivier Pajot; Denis Garot; Tài Pham; Xavier Capdevila; Dominique Perrotin; Karim Lakhal
Journal:  Crit Care Med       Date:  2013-04       Impact factor: 7.598

3.  Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness.

Authors:  Xavier Valette; Benoit Savary; Marie Nowoczyn; Cédric Daubin; Véronique Pottier; Nicolas Terzi; Amélie Seguin; Sabine Fradin; Pierre Charbonneau; Jean-Luc Hanouz; Damien du Cheyron
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

4.  Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study.

Authors:  Cynthia M Cely; Roland M H Schein; Andrew A Quartin
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097
  4 in total
  1 in total

1.  Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness: reply to Quartin et al.

Authors:  Xavier Valette; Damien du Cheyron
Journal:  Intensive Care Med       Date:  2013-10-01       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.